GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (MEX:KVUE) » Definitions » Investments And Advances

Kenvue (MEX:KVUE) Investments And Advances : MXN0 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Investments And Advances?

Kenvue's Investments And Advances for the quarter that ended in Mar. 2025 was MXN0 Mil.

Kenvue Investments And Advances Historical Data

The historical data trend for Kenvue's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Investments And Advances Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial - - - - -

Kenvue Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kenvue Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Kenvue Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (MEX:KVUE) » Definitions » Investments And Advances
Comparable Companies
KMB CHD EL CLX CL HIMS ELF IPAR COTY NWL PG XPAR:OR LSE:ULVR BOM:500696 LSE:RKT XTER:HEN3 XTER:BEI TSE:4452 OSTO:ESSITY B BOM:532424
Traded in Other Exchanges
KVUE:USA J4D:Germany
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Website
https://www.kenvue.com
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.